Becker's ASC Review

June 2022 Issue of Becker's ASC Review

Issue link: https://beckershealthcare.uberflip.com/i/1471343

Contents of this Issue

Navigation

Page 31 of 39

32 GASTROENTEROLOGY How gastroenterologist pay has changed in the past 10 years By Patsy Newitt Gastroenterology is consistently among the top 10 highest-paid physician specialties, according to Medscape's Physicians Compensa- tion Reports. Here's how gastroenterologist pay has changed over the past 10 years and its ranking among the highest-earning specialties: Is private equity worth it for gastroenterology practices? By Patsy Newitt Private equity is thriving in gastroenterology, with several equity- backed management groups taking over the market. The number of private equity gastrointestinal groups grew by 28 per- cent, to 68, in 2021, according to a report jointly published by consult- ing firm Fraser Healthcare and pharma research firm Spherix Global Insights. The influx of investment, however, is controversial, and many gastroen- terologists warn against the cons of a private equity investment. "This trend has seen growing momentum in the past five years. The field presents an attractive PE target, as a significant portion of gastro- enterologists remain in independent practices with ownership in am- bulatory endoscopy centers," Rami Abbass, MD, a gastroenterologist at University Hospitals in Mentor, Ohio, told Becker's. "The growing regulatory environment, high cost of capital, administrative burdens and challenges of partner recruitment have made private equity at- tractive to some practices. " The high upfront acquisition payment has to be weighed against a potential loss of autonomy, Dr. Abbass said. For these relationships to thrive, physician partners and equity firms need to have shared values and a deep understanding of the regional landscape. But for many gastroenterologists, private equity is the key to thrive and pass on a legacy. "The one thing which I'm very happy about, thank God, is private eq- uity," Rajiv Sharma, MD, owner of Digestive Health Associates in Terre Haute, Ind., told Becker's. "Private equity was perfect for me. Now I have access to capital, right? One thing which always bothered me was for GIs and other practices, unlike other businesses, we really don't have very clear legacy planning. " n 2022: $453,000 Ranking: 6 2021: $406,000 Ranking: 7 2020: $419,000 Ranking: 6 2019: $417,000 Ranking: 7 2018: $408,000 Ranking: 4 2017: $391,000 Ranking: 7 2016: $380,000 Ranking: 4 2015: $370,000 Ranking: 3 2014: $348,000 Ranking: 3 2013: $342,000 Ranking: 4 n AmSurg at the center of $2.5B Envision lender dispute By Laura Dyrda E nvision Healthcare moved AmSurg, which made up around half of the physician staffing firm's earnings last year, to a new affiliate, according to The Wall Street Journal. Envision inked a deal led by investment firms Centerbridge Partners LP and Angelo Gor- don & Co. to move about $2.5 billion in col- lateral away from existing lenders so it could borrow up to $1.3 billion in first-lien loans and $1.3 billion in second-lien loans as part of a plan to repurchase existing debt. The debt repurchase program is expected to low- er Envision's indebtedness by around $600 million, but the lenders aren't happy. Existing lenders said the deal came at their expense, and the lenders are now consider- ing filing a lawsuit, according to the report. The lenders said the deal may violate Envi- sion's debt documents. Envision said it thinks the move is allowed within the terms of their loan documents. Around 80 percent of AmSurg was moved to a new corporate subsidiary, according to the report. n

Articles in this issue

view archives of Becker's ASC Review - June 2022 Issue of Becker's ASC Review